Lutz Kloke, Founder of Cellbricks GmbH
Professional Overview
Lutz Kloke is the Founder of Cellbricks GmbH, a leading biotechnology company based in Berlin, Germany. With his strong background in pharmaceutical research and development, Kloke has established Cellbricks as a pioneering force in the field of bioprinting and tissue engineering.
Experience Summary
Current Role
As the Founder of Cellbricks GmbH, Kloke is responsible for driving the company's strategic vision, overseeing product development, and fostering collaborative partnerships with academic institutions and industry leaders. Under his leadership, Cellbricks has become a recognized innovator in the application of 3D bioprinting technologies to create advanced tissue models and regenerative medicine solutions.
Career Progression
Kloke's professional journey began as a Pharmacist at St. Laurentius Apotheke, where he gained valuable experience in the pharmaceutical industry. He then transitioned to a Research Scientist role at the Deutsches Rheuma-Forschungszentrum, where he conducted cutting-edge research in the field of rheumatology.
Kloke's academic pursuits led him to the Technische Universität Berlin, where he completed his Ph.D. studies, focusing on the development of novel biomaterials and tissue engineering approaches. This research experience laid the foundation for his entrepreneurial endeavors, and in 2015, he founded Cellbricks GmbH to commercialize his innovative bioprinting technologies.
Academic Background
Kloke holds a Ph.D. in Biomedical Engineering from the Technische Universität Berlin, where he specialized in the development of advanced biomaterials and 3D bioprinting techniques. His academic achievements and research contributions have been recognized through various awards and publications in peer-reviewed journals.
Areas of Expertise
- Bioprinting and tissue engineering
- Biomaterials development and characterization
- Pharmaceutical research and development
- Entrepreneurship and innovation in the biotech industry
Professional Impact
Under Kloke's leadership, Cellbricks has emerged as a leading player in the 3D bioprinting market, collaborating with prominent academic institutions and industry partners to advance the field of regenerative medicine. The company's innovative bioprinting solutions have been instrumental in the development of personalized tissue models and cutting-edge therapeutic applications.
Conclusion
Lutz Kloke's diverse background, exceptional technical expertise, and entrepreneurial spirit have positioned him as a driving force in the biotechnology industry. As the Founder of Cellbricks GmbH, he continues to push the boundaries of bioprinting and tissue engineering, contributing to the advancement of regenerative medicine and the development of transformative healthcare solutions.
